New York, Global Lyme Disease – Drug Pipeline Landscape, 2022 report from Global Insight Services is the single authoritative source of intelligence on Lyme Disease – Drug Pipeline Landscape, 2022. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash.
Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems.
Diagnosis of Lyme disease involves lab tests to identify antibodies to the bacteria can help confirm or rule out the diagnosis. They include ELISA test, Western blot test and polymerase chain reaction test.
Request sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS31045/
Lyme disease is treated by using oral antibiotics and intravenous antibiotics. Doxycycline, amoxicillin, or cefuroxime antibiotics are used for treatment.
The companies active in the development of Lyme Disease Drugs include Valneva, Tarsus Pharmaceuticals, Cortene etc.
Clinical trials are ongoing for several drugs in development for Lyme disease. These drugs are in various stages of development, from early preclinical stages to late-stage clinical trials.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS31045/
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS31045/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700